Research and Development

The Research and Development team at Cornerstone Pharmaceuticals focuses on advancing innovative metabolic oncology therapeutics through rigorous scientific research and clinical evaluation. Led by the Chief Scientist and Chief Medical Officer, the team collaborates to design and implement preclinical and clinical studies, ensuring the safety and efficacy of new treatments while adhering to regulatory standards. Their collective expertise drives the discovery and development of groundbreaking therapies aimed at improving patient outcomes in cancer care.